Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-01-12
Summary
This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.
Conditions
- Liver Carcinoma
Interventions
- RADIATION
-
18F-RD2
Patients will receive 5-10 mCi 18F-RD2
Sponsors & Collaborators
-
Affiliated Hospital of Jiangnan University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-24
- Primary Completion
- 2022-11-02
- Completion
- 2022-12-20
Countries
- China
Study Locations
More Related Trials
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
18F-LN1 PET/CT in Urothelial Carcinomas
NCT06120413 ·Status: RECRUITING
-
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
NCT05030597 ·Status: RECRUITING
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy
NCT05662488 ·Status: UNKNOWN
-
68Ga-labeled NY104 PET Imaging in Patients
NCT05638256 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
NCT05983796 ·Status: UNKNOWN ·Phase: NA
-
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
NCT03768479 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
NCT04813705 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
NCT06945432 ·Status: COMPLETED
-
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
NCT06165874 ·Status: RECRUITING ·Phase: NA
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07301801 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED